Intrusion released FY2024 Q3 earnings on November 12 After-Market (EST), actual revenue $1.504M (forecast $1.575M), actual EPS -0.35 (forecast -0.42)

Brief Summary

Intrusion reported a Q3 2024 revenue of $1.504 million and an EPS of -$0.35, missing revenue expectations but surpassing EPS expectations.

Impact of The News

1. Comparison with Expectations:

• The actual revenue of Intrusion was $1.504 million, which fell short of the expected $1.58 million.
• However, the EPS of -$0.35 exceeded market expectations of -$0.42, indicating a smaller loss than anticipated.

2. Peer Benchmarking:

• When comparing to other companies like Applovin and Zeta Global in the technology sector, which reported significant revenue growth and surpassed expectations , Intrusion’s performance appears weaker in terms of revenue.
• Moreover, other companies like Pyxis Oncology and Centessa Pharmaceuticals also reported negative EPS, but Intrusion’s results show a relative improvement by beating the EPS forecast.

3. Business Status and Trends:

• The negative earnings per share signify that Intrusion is still operating at a loss, although the smaller than expected loss might indicate some cost control or operational efficiency.
• The shortfall in revenue suggests challenges in sales or market demand, which the company will need to address to improve its financial health.
• Moving forward, Intrusion needs to enhance its revenue generation capabilities to meet or exceed market expectations, potentially through strategic partnerships, enhancing product offerings, or expanding market reach.